HCA Healthcare Inc
HCA: XNYS (USA)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| ^X? | LOCK|g<L! | LOCK|&kN?$c |
HCA Earnings: Benefits From Elevated Medical Utilization Boost 2025 Guidance
HCA turned in 6% revenue growth in the quarter, and including margin expansion and share repurchases, adjusted EPS grew 24% year over year. On these results, management raised its guidance for 2025, including adjusted EPS of $25.50-$27.00, up from $24.05-$25.85 previously.
